News

Filter

Current filters:

Metabolicspramlintide

Amylin and Takeda drop combo obesity drug development

08-08-2011

Amylin Pharmaceuticals (Nasdaq: AMLN) and Japan’s Takeda Pharmaceutical (TSE: 4502) are discontinuing…

AmylinMetabolicsmetreleptinPharmaceuticalpramlintideResearchTakeda Pharmaceuticals

Amylin and Takeda voluntarily stop Ph II obesity drug trial

17-03-2011

USA-based Amylin Pharmaceuticals (Nasdaq: AMLN) and Japanese development partner Takeda Pharmaceutical…

AmylinMetabolicsmetreleptinPharmaceuticalpramlintideResearchTakeda Pharmaceuticals

Back to top